Operating Expenses Zmiana Data
AbbVie USD 11.11B 540M 2023-12
Agios Pharmaceuticals USD 113.38M 5.08M 2023-12
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Amgen USD 6.93B 2.11B 2023-12
Arrowhead Research USD 140.1M 15.67M 2023-12
Astellas Pharma JPY 386.93B 57.73B 2023-09
AstraZeneca USD 9.54B 578M 2023-09
Bayer EUR 13.94B 1.94B 2023-09
Biogen USD 2.03B 344.1M 2023-12
BioMarin Pharmaceutical USD 631.99M 76.32M 2023-12
Bluebird Bio USD 97.12M 4.93M 2023-09
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Daiichi Sankyo JPY 324.48B 17.68B 2023-09
Eli Lilly USD 6.97B 2.08B 2023-12
Exelixis USD 489.5M 97.5M 2023-09
Gilead Sciences USD 5.5B 1.08B 2023-12
GlaxoSmithKline GBP 6.2B 1.16B 2023-09
Incyte USD 826.07M 121.75M 2023-12
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
Merck USD 16.56B 6.35B 2023-12
Moderna USD 2.8B 1.04B 2023-12
Nektar Therapeutics USD 69.01M 2.09M 2023-09
Pfizer USD 20.8B 4.62B 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
Sarepta Therapeutics USD 380.16M 87.4M 2023-09
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09



Agios Pharmaceuticals Koszty Operacyjne - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.